Scott Armstrong is the Chairman of Pediatric Oncology at the Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology and Oncology at Boston Children’s Hospital. Scott Armstrong studies the mechanisms of cancer development, focusing on leukemia. One major interest of this lab is the relationship between leukemia, normal hematopoietic stem cells and the various hematopoietic cells of origin of leukemia. The Armstrong lab is also studying the role of histone modifications and chromosome structure as a critical initial step in cancer development and how these mechanisms can be targeted therapeutically. His work has led to the development of new therapeutic approaches for multiple types of cancer that are now being tested. His work has been recognized by multiple awards including the Till and McCulloch Award from the International Society of Experimental Hematology, the Paul Marks Prize for Cancer Research from Memorial Sloan Kettering Cancer Center, the E. Mead Johnson Award from the Society for Pediatric Research, and the Dameshek Prize from the American Society of Hematology. Armstrong is an elected member of the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), and a fellow of the Association for the Advancement of Science.
Lab Website: https://www.dana-farber.org/find-a-doctor/scott-a-armstrong